Possibility of Human Embryo Genome Editing Continues to be Debated
Онтогенез / Russian Journal of Developmental Biology · 2025
DOI: 10.7868/s3034626625020021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Онтогенез / Russian Journal of Developmental Biology, 2025. Verfasst von K. S. Sharov.
Abstract (Originalsprache)
In 2021, the International Society for Stem Cell Research (ISSCR) cancelled the famous “Rule of 14 days” that has been regulating research on human embryos. This led to the emergence of novel controversial problems in bioethics, which are related to prospects of human genome editing in embryo. Theoretically, one can treat more than ten thousand inherited diseases with the use of gene editing techniques. Practically, these techniques have already been applied for treating a number of adults’ diseases. However, therapy based on gene editing technologies did not always lead to positive effects. Moreover, one may ask, whether these techniques can be used for gene editing of human embryos and gametes so that healthy children would be born that would have hereditary diseases otherwise. In this brief communication, we consider arguments “in favour” and “against”. We conclude that risks overweigh the potential good at this stage of gene editing techniques development.
Zitieren
APA
Sharov, K. S. (2025). Possibility of Human Embryo Genome Editing Continues to be Debated. Онтогенез / Russian Journal of Developmental Biology. https://doi.org/10.7868/s3034626625020021
Vancouver
Sharov KS. Possibility of Human Embryo Genome Editing Continues to be Debated. Онтогенез / Russian Journal of Developmental Biology. 2025. doi:10.7868/s3034626625020021
BibTeX
@article{Sharov2025,
author = {Sharov, K. S.},
title = {Possibility of Human Embryo Genome Editing Continues to be Debated},
journal = {Онтогенез / Russian Journal of Developmental Biology},
year = {2025},
doi = {10.7868/s3034626625020021}
}
EUVIMED